Study of the expression levels of miR143 and miR183 affecting the target gene RICTOR and clinicopathological examination of samples in paraffin-embedded tissues of gastric adenocarcinoma

Study of the expression levels of miR143 and miR183 affecting the target gene RICTOR and clinicopathological examination of samples in paraffin-embedded tissues of gastric adenocarcinoma

dr faranak jamshidian1 sarah neematkhah2

1) Assistant Professor of Biology-Molecular Genetics, East Tehran Branch
2) Master of Science in Genetic Engineering, Islamic Azad University, East Tehran Branch

IOI Code : AADK-AABFAE
Publication : 3rd International Congress on Science, engineering & New Technologies(secongress.com/3rd)
Abstract :
    Cancer has affected many people for years and is the second leading cause of death worldwide after cardiovascular diseases. Cancer is a highly complex genetic, epigenetic, and environmental disease with great diversity at the tissue, tumor, and cellular levels. Scientists are trying to accurately identify the mutations involved in the development of each cancer and suggest the best option for each patient s treatment regimen, in order to prevent the side effects of chemotherapy as much as possible and maximize the efficiency of treatment. Researchers have proposed several sequences as a therapeutic approach that, if successful, can be considered very successful in the fight against cancer. One of the most suitable solutions is to design chemotherapy drugs based on the weaknesses of cancer cells, which allows treatment to be personalized and specific for each patient to achieve the highest efficiency with minimal side effects. In this context, targeting cellular signaling pathways including EGFR and RAS, the angiogenesis pathway, and the genome repair pathway have yielded successful results so far. Another approach under investigation is the use of targeted and efficient drug delivery methods, for which nanoparticles, miRNAs, and siRNAs have been successful so far (1). In this study, we investigated gastric cancer, which is the second most common cause of death in countries worldwide and whose epidemiology has changed in recent decades (2). RICTOR was evaluated in vitro in cell proliferation, apoptosis, migration, and invasion by RNA interference.

Keywords : gastric cancer therapeutic approach clinicopathology